Inventor
Roberto Iacone
Inventor
Basel, CH
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes19%
C12NMicroorganisms or enzymes15%
C07KPeptides12%
C07CAcyclic or carbocyclic compounds8%
C07DHeterocyclic compounds8%
C07BGeneral methods of organic chemistry4%
C12YEnzymes4%
PatentTitleYear
11,059,858Difluoroketamide derivatives as HtrA1 inhibitors202111,014,963Trifluoromethylpropanamide derivatives as HTRA1 inhibitors202110,724,000Small molecule based conversion of somatic cells into neural crest cells202010,519,450Antisense oligonucleotides for modulating HTRA1 expression201910,428,108Difluoroketamide derivatives201910,138,468Method for differentiation of pluripotent stem cells into multi-competent renal precursors20189,980,929Trifluoromethylpropanamide derivatives20189,297,025'Conversion of somatic cells to induced reprogrammed neural stem cells (irNSCs)'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2021Patents assigned to HOFFMANN LA ROCHE (8)· patent assignee history
2016–2021Based in Basel, CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOFFMANN LA ROCHE | 8 | 2016–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Basel, CH | 8 | 2016–2021 |